Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.44461 | 56 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.43426 | 57 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.42708 | 56 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.52673 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.10004 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.58263 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.6214 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.41158 | 56 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50676 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.43312 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.41905 | 56 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.18979 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.4422 | 56 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.42434 | 56 |